These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
447 related articles for article (PubMed ID: 28534084)
1. The emerging link between O-GlcNAcylation and neurological disorders. Ma X; Li H; He Y; Hao J Cell Mol Life Sci; 2017 Oct; 74(20):3667-3686. PubMed ID: 28534084 [TBL] [Abstract][Full Text] [Related]
2. O-GlcNAcylation and Its Roles in Neurodegenerative Diseases. Du P; Zhang X; Lian X; Hölscher C; Xue G J Alzheimers Dis; 2024; 97(3):1051-1068. PubMed ID: 38250776 [TBL] [Abstract][Full Text] [Related]
4. Proteomic identification of altered protein O-GlcNAcylation in a triple transgenic mouse model of Alzheimer's disease. Tramutola A; Sharma N; Barone E; Lanzillotta C; Castellani A; Iavarone F; Vincenzoni F; Castagnola M; Butterfield DA; Gaetani S; Cassano T; Perluigi M; Di Domenico F Biochim Biophys Acta Mol Basis Dis; 2018 Oct; 1864(10):3309-3321. PubMed ID: 30031227 [TBL] [Abstract][Full Text] [Related]
5. Cryo-EM structure of human O-GlcNAcylation enzyme pair OGT-OGA complex. Lu P; Liu Y; He M; Cao T; Yang M; Qi S; Yu H; Gao H Nat Commun; 2023 Oct; 14(1):6952. PubMed ID: 37907462 [TBL] [Abstract][Full Text] [Related]
6. Developmental regulation of protein O-GlcNAcylation, O-GlcNAc transferase, and O-GlcNAcase in mammalian brain. Liu Y; Li X; Yu Y; Shi J; Liang Z; Run X; Li Y; Dai CL; Grundke-Iqbal I; Iqbal K; Liu F; Gong CX PLoS One; 2012; 7(8):e43724. PubMed ID: 22928023 [TBL] [Abstract][Full Text] [Related]
7. The Dysregulation of OGT/OGA Cycle Mediates Tau and APP Neuropathology in Down Syndrome. Zuliani I; Lanzillotta C; Tramutola A; Francioso A; Pagnotta S; Barone E; Perluigi M; Di Domenico F Neurotherapeutics; 2021 Jan; 18(1):340-363. PubMed ID: 33258073 [TBL] [Abstract][Full Text] [Related]
8. O-GlcNAcylation as a Therapeutic Target for Alzheimer's Disease. Park J; Lai MKP; Arumugam TV; Jo DG Neuromolecular Med; 2020 Jun; 22(2):171-193. PubMed ID: 31894464 [TBL] [Abstract][Full Text] [Related]
13. [Protein O-GlcNAcylation and regulation of cell signalling: involvement in pathophysiology]. Issad T; Pagesy P Biol Aujourdhui; 2014; 208(2):109-17. PubMed ID: 25190571 [TBL] [Abstract][Full Text] [Related]
14. Hexosamine biosynthetic pathway and Kim DY; Park J; Han IO Am J Physiol Cell Physiol; 2023 Oct; 325(4):C981-C998. PubMed ID: 37602414 [TBL] [Abstract][Full Text] [Related]
15. Aβ-affected pathogenic induction of S-nitrosylation of OGT and identification of Cys-NO linkage triplet. Ryu IH; Lee KY; Do SI Biochim Biophys Acta; 2016 May; 1864(5):609-21. PubMed ID: 26854602 [TBL] [Abstract][Full Text] [Related]
16. Intracellular and extracellular O-linked N-acetylglucosamine in the nervous system. Ogawa M; Sawaguchi S; Kamemura K; Okajima T Exp Neurol; 2015 Dec; 274(Pt B):166-74. PubMed ID: 26278182 [TBL] [Abstract][Full Text] [Related]
17. Hijacking of the O-GlcNAcZYME complex by the HTLV-1 Tax oncoprotein facilitates viral transcription. Groussaud D; Khair M; Tollenaere AI; Waast L; Kuo MS; Mangeney M; Martella C; Fardini Y; Coste S; Souidi M; Benit L; Pique C; Issad T PLoS Pathog; 2017 Jul; 13(7):e1006518. PubMed ID: 28742148 [TBL] [Abstract][Full Text] [Related]
18. Site-specific interplay between O-GlcNAcylation and phosphorylation in cellular regulation. Hu P; Shimoji S; Hart GW FEBS Lett; 2010 Jun; 584(12):2526-38. PubMed ID: 20417205 [TBL] [Abstract][Full Text] [Related]
19. Emerging roles of protein O-GlcNAcylation in cardiovascular diseases: Insights and novel therapeutic targets. Bolanle IO; Riches-Suman K; Williamson R; Palmer TM Pharmacol Res; 2021 Mar; 165():105467. PubMed ID: 33515704 [TBL] [Abstract][Full Text] [Related]
20. Reduced O-GlcNAcylation links lower brain glucose metabolism and tau pathology in Alzheimer's disease. Liu F; Shi J; Tanimukai H; Gu J; Gu J; Grundke-Iqbal I; Iqbal K; Gong CX Brain; 2009 Jul; 132(Pt 7):1820-32. PubMed ID: 19451179 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]